Neuberger Berman Group
CERE

Neuberger Berman Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Neuberger Berman Group’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-80,912
Closed -$2.57M – 1883
2023
Q2 		$2.57M Buy
80,912
+45,839
+131% +$1.46M ﹤0.01% 1028
2023
Q1 		$855K Sell
35,073
-36,419
-51% -$888K ﹤0.01% 1303
2022
Q4 		$2.25M Buy
+71,492
New +$2.25M ﹤0.01% 1048